These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 21198520)

  • 1. Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.
    Rademaker M
    Australas J Dermatol; 2010 Nov; 51(4):248-53. PubMed ID: 21198520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose schema of isotretinoin in acne vulgaris.
    Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G
    Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On isotretinoin dosing, adverse effects, and efficacy.
    Berk DR
    Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
    [No Abstract]   [Full Text] [Related]  

  • 5. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric reactions to isotretinoin in patients with bipolar disorder.
    Schaffer LC; Schaffer CB; Hunter S; Miller A
    J Affect Disord; 2010 May; 122(3):306-8. PubMed ID: 19783054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
    Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
    Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotretinoin treatment in patients with acne vulgaris: does it impact muscle strength, fatigue, and endurance?
    Yıldızgören MT; Rifaioğlu EN; Demirkapı M; Ekiz T; Micooğulları A; Şen T; Turhanoğlu AD
    Cutis; 2015 Jul; 96(1):33-6. PubMed ID: 26244352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myopathy and acne fulminans triggered by isotretinoin therapy.
    Sarifakioglu E; Onur O; Kart H; Yilmaz AE
    Eur J Dermatol; 2011; 21(5):794-5. PubMed ID: 21727056
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
    Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety issues in isotretinoin therapy.
    Hanson N; Leachman S
    Semin Cutan Med Surg; 2001 Sep; 20(3):166-83. PubMed ID: 11594672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
    Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
    J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Layton AM; Dréno B; Gollnick H; Mobaken H; Shear N
    Br J Dermatol; 2009 Jan; 160(1):217-8; author reply 218-9. PubMed ID: 19067687
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
    DiGiovanna JJ; Langman CB; Tschen EH; Jones T; Menter A; Lowe NJ; Eichenfield L; Hebert AA; Pariser D; Savin RP; Smith SR; Jarratt M; Rodriguez D; Chalker DK; Kempers S; Ling M; Rafal ES; Sullivan S; Kang S; Shah LP; Wu E; Newhouse J; Pak J; Eberhardt DR; Bryce GF; McLane JA; Ondovik M; Chin C; Khoo KC; Rich P
    J Am Acad Dermatol; 2004 Nov; 51(5):709-17. PubMed ID: 15523348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood changes, depression and suicide risk during isotretinoin treatment: a prospective study.
    Nevoralová Z; Dvořáková D
    Int J Dermatol; 2013 Feb; 52(2):163-8. PubMed ID: 23347302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological impact of isotretinoin treatment in patients with moderate and severe acne.
    Simić D; Situm M; Letica E; Penavić JZ; Zivković MV; Tomić T
    Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral isotretinoin for acne, adjusting treatment according to patient's response.
    Ghaffarpour G; Mazloomi S; Soltani-Arabshahi R; Seyed KS
    J Drugs Dermatol; 2006 Oct; 5(9):878-82. PubMed ID: 17039654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne.
    Kaymak Y; Ilter N
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1256-60. PubMed ID: 17062042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.